Prevalence and incidence of autism spectrum disorder in an Israeli population

Journal of Autism and Developmental Disorders

Volumn 43, Issue 4, 2013, Pages 785-793

  Davidovitch, Michael ^a   Hemo, Beatriz ^a   Manning Courtney, Patricia ^b   Fombonne, Eric ^c  

^a MACCABI HEALTHCARE SERVICES   (Israel)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Autism spectrum disorder (ASD); Incidence; Israel; Prevalence

Indexed keywords

ARTICLE; AUTISM; CALCULATION; CHILD; FEMALE; HUMAN; INFANT; ISRAEL; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MORBIDITY; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; ISRAEL; MALE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SOCIOECONOMIC FACTORS;

EID: 84879459193     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-012-1611-z     Document Type: Article

References (31)

1. American Psychiatric Association. (1994). Diagnostic and statisticalmanual of mental disorders (DSM-IV). Washington, DC: American Psychiatric Press.
2. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention (CDC). (2009). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. Morbidity and Mortality Weekly Report. Surveillance Summaries, 18(10), 1-20.
3. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators. (2012). Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2008. Morbidity and Mortality Weekly Report. Surveillance Summaries, 30(3), 1-19.
4. Bishop, D. V., Whitehouse, A. J., Watt, H. J., & Line, E. A. (2008). Autism and diagnostic substitution: Evidence from a study of adults with a history of developmental language disorder. Developmental Medicine and Child Neurology, 50(5), 341-345. (Pubitemid 351560293)
5. Davidovitch, M., Golan, D., Vardi, O., Lev, D., & Lerman-Sagie, T. (2011). Israeli children with autism spectrum disorder are not macrocephalic. Journal of Child Neurology, 26(5), 580-585.
6. Davidovitch, M., Holtzman, G., & Tirosh, E. (2001). Autism in the Haifa area - an epidemiological perspective. The Israel Medical Association Journal, 3(3), 188-189. (Pubitemid 32432967)
7. Durkin, M. S., Maenner, M. J., Meaney, F. J., Levy, S. E., DiGuiseppi, C., Nicholas, J. S., et al. (2010). Socioeconomic inequality in the prevalence of autism spectrum disorder: Evidence from a U.S. cross-sectional study. PLoS One, 12(5), e11551.
8. Elsabbagh, M., Divan, G., Koh, Y. J., Kim, Y. S., Kauchali, S., Marcín, C., et al. (2012). Global prevalence of autism and other pervasive developmental disorders. Autism Research, 5(3), 160-179.
9. Fombonne, E., Quirke, S., & Hagen, A. (2011). Epidemiology of pervasive developmental disorders. In D. G. Amaral, G. Dawson, & D. H. Geschwind (Eds.), Autism spectrum disorders (pp. 90-111). New York: Oxford University Press.
10. Gal, G., Abiri, L., Reichenberg, A., Gabis, L., & Gross, R. (2012). Time trends in reported autism spectrum disorders in Israel, 1986-2005. Journal of Autism and Developmental Disorder, 42(3), 428-431.
11. Gal, G., & Gross, R. (2009). Time trends and autism. The Israel Medical Association Journal, 11(9), 577.
12. Hertz-Picciotto, I., & Delwiche, L. (2009). The rise in autism and the role of age at diagnosis. Epidemiology, 20(1), 84-90.
13. IBM Reference #1480127. (2012). Cochran-Armitage test for trend for 2xI tables. http://www-01.ibm.com/support/docview.wss?uid=swg21480127. Modified 04.01.2012.
14. Israeli Central Bureau of Statistics. (2006). http://www.cbs.gov.il/ publications/local-authorities2006/excel/p-libud.xls.
15. Israeli Central Bureau of Statistics-National Insurance Institute. (2010). http://www.cbs.gov.il/q153-heb.htm.
16. Jick, H., Beach, K. J., & Kaye, J. A. (2006). Incidence of autism over time. Epidemiology, 17(1), 120-121.
17. Jick, H., & Kaye, J. A. (2003). Epidemiology and possible causes of autism. Pharmacotherapy, 23(12), 1524-1530. (Pubitemid 37485303)
18. Kim, Y. S., Leventhal, B. L., Koh, Y. J., Fombonne, E., Laska, E., Lim, E. C., et al. (2011). Prevalence of autism spectrum disorders in a total population sample. American Journal of Psychiatry, 168(9), 904-912.
19. King, M., & Bearman, P. (2009). Diagnostic change and the increased prevalence of autism. International Journal of Epidemiology, 38(5), 1224-1234.
20. Kogan, M. D., Blumberg, S. J., Schieve, L. A., Boyle, C. A., Perrin, J. M., & Ghandour, R. M. (2009). Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics, 124, 1395-1403.
21. Lazoff, T., Zhong, L., Piperni, T., & Fombonne, E. (2010). Prevalence of pervasive developmental disorders among children at the English Montreal School Board. Canadian Journal of Psychiatry, 55(11), 715-720.
22. Lord, C., Rutter, M., Dilavore, P., & Risi, S. (2008). Autism diagnostic observation schedule manual. Los Angeles, CA: Western Psychological Services.
23. Mandell, D. S., Wiggins, L. D., Carpenter, L. A., Daniels, J., DiGuiseppi, C., Durkin, M. S., et al. (2009). Racial/ethnic disparities in the identification of children with autism spectrum disorders. American Journal of Public Health, 99(3), 493-498.
24. Molloy, C. A., Murray, D. S., Akers, R., Mitchell, T., & Manning-Courtney, P. (2011). Use of the Autism Diagnostic Observation Schedule (ADOS) in a clinical setting. Autism, 15(2), 143-162.
25. Posserud, M., Lundervold, A. J., Lie, S. A., & Gillberg, C. (2010). The prevalence of autism spectrum disorders: Impact of diagnostic instrument and non-response bias. Social Psychiatry and Psychiatric Epidemiology, 45(3), 319-327.
26. Powell, J. E., Edwards, A., Edwards, M., Pandit, B. S., Sungum-Paliwal, S. R., & Whitehouse, W. (2000). Changes in the incidence of childhood autism and other autistic spectrum disorders in preschool children from two areas of the West Midlands, UK. Developmental Medicine and Child Neurology, 42(9), 624-628.
27. Senecky, Y., Chodick, G., Diamond, G., Lobel, D., Drachman, R., & Inbar, D. (2009). Time trends in reported autistic spectrum disorders in Israel, 1972-2004. The Israel Medical Association Journal, 11(1), 30-33.
28. Shelton, J. F., Hertz-Picciotto, I., Pessah, I. N. (2012). Tipping the balance of autism risk: Potential mechanisms linking pesticides and autism. Environ Health Perspect. Apr 11.
29. Smeeth, L., Cook, C., Fombonne, E., Heavey, L., Rodrigues, L. C., Smith, P. G., et al. (2004). MMR vaccination and pervasive developmental disorders: A case-control study. Lancet, 364, 963-969. (Pubitemid 39208457)
30. Wazana, A., Bresnahan, M., & Kline, J. (2007). The autism epidemic: Fact or artifact? Journal of the American Academy of Child and Adolescent Psychiatry, 46(6), 721-730. (Pubitemid 46816825)
31. Wong, V. C., & Hui, S. L. (2008). Epidemiological study of autism spectrum disorder in China. Journal of Child Neurology, 23, 67-72.